Amsacrine
Top View
- Isolation and Preliminary Characterization of an Adriamycin-Resistant Murine Fibrosarcoma Cell Line1
- Inhibitors of the Menin-Mll Interaction Inhibitoren Der Menin-Mll-Interaktion Inhibiteurs De L’Interaction Ménine-Mll
- Teniposide Injection
- The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia
- 1. NAME of the MEDICINAL PRODUCT Amsidine, Concentrate for Solution for Intravenous Infusion 75 Mg/ 1,5 Ml 2. QUALITATIVE and QU
- Synthesis, Antitumor Activity, and DMA Binding Properties of A
- The Hi S and Lo S of Cytarabine in Acute Myeloid Leukemia
- NCCN Guidelines for Acute Myeloid Leukemia from the 1.2014 Version Include
- Randomized Trial of Intermediate-Dose Cytarabine In
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Liste Des Molécules
- The DNA Topoisomerase II Inhibitor Amsacrine As a Novel Candidate
- Camptothecin, Teniposide, Or 4
- (12) United States Patent (10) Patent No.: US 6,664,288 B1 Pardee Et Al
- Arsenic Trioxide (As 2 O 3) Gradually Downregulates Tissue Factor
- Orphan Drugs in Asia Report 2014
- Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA
- Neutropenic Enterocolitis in a Woman Treated with 5-Fluorouracil and Leucovorin for Colon Carcinoma